Sznol, M., Kluger, H. M., Wong, P. F., Smithy, J. W., Rimm, D. L., Pelekanou, V., . . . Neumeister, V. M. Nuclear IRF-1 expression as a mechanism to assess “Capability” to express PD-L1 and response to PD-1 therapy in metastatic melanoma. BMJ Publishing Group.
Chicago Style (17th ed.) CitationSznol, Mario, et al. Nuclear IRF-1 Expression as a Mechanism to Assess “Capability” to Express PD-L1 and Response to PD-1 Therapy in Metastatic Melanoma. BMJ Publishing Group.
MLA (9th ed.) CitationSznol, Mario, et al. Nuclear IRF-1 Expression as a Mechanism to Assess “Capability” to Express PD-L1 and Response to PD-1 Therapy in Metastatic Melanoma. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.